基础研究
Copyright ©The Author(s) 2005.
世界华人消化杂志. 2005-08-28; 13(16): 1985-1991
在线出版 2005-08-28. doi: 10.11569/wcjd.v13.i16.1985
表1 celecoxib与CPT-11、CPT、TPT 联合应用对人结肠癌细胞系化学敏感性的影响(n = 3)
细胞系CPT-11
CPT
TPT
IC50(μmol/L)RR1IC50(nmol/L)RRIC50(nmol/L)RR
HT-297.12±3.151.0064.60±30.921.0087.93±13.331.00
HT-29/Cele 123.77±1.941.8937.00±20.611.7519.23±5.974.57
HT-29/Cele 50.21±0.0634.031.89±0.5734.242.38±1.8137.00
HCT-853.43±37.101.00542.67±348.501.00512.33±162.531.00
HCT-8/Cele 168.00±32.820.7947.60±40.2011.40163.00±36.043.14
HCT-8/Cele 51.04±0.1951.607.16±10.6975.837.75±5.8566.11
HCT-11666.57±23.781.00358.67±203.821.0059.70±35.201.00
HCT-116/Cele 125.93±12.872.57216.67±87.561.6627.30±4.482.19
HCT-116/Cele 58.98±5.127.4138.57±16.689.3015.07±3.843.96
Caco-216.00±5.371.00337.00±199.971.00642.00±75.971.00
Caco-2/Cele 18.22±5.711.95233.00±19.001.4456.83±51.2511.30
Caco-2/Cele 51.05±0.3115.2444.07±14.167.656.88±3.0793.35

引文著录: 付剑江, 李燕, 李洪燕, 刘悦, 陈晓光. 氧合酶-2抑制剂celecoxib与喜树碱类衍生物联合用药的实验研究. 世界华人消化杂志 2005; 13(16): 1985-1991